<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo270077" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39991264</article-id><article-id pub-id-type="pmc">PMC11843471</article-id>
<article-id pub-id-type="doi">10.1002/deo2.70077</article-id><article-id pub-id-type="publisher-id">DEO270077</article-id><article-categories><subj-group subj-group-type="overline"><subject>Techniques and Innovation</subject></subj-group><subj-group subj-group-type="heading"><subject>Techniques and Innovation</subject></subj-group></article-categories><title-group><article-title>Oxygen saturation imaging elucidates tumor heterogeneity in gastric cancer</article-title><alt-title alt-title-type="left-running-head">MINAMIDE <sc>et&#x000a0;al</sc>.</alt-title></title-group><contrib-group><contrib id="deo270077-cr-0001" contrib-type="author"><name><surname>Minamide</surname><given-names>Tatsunori</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1323-416X</contrib-id><xref rid="deo270077-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo270077-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo270077-cr-0002" contrib-type="author"><name><surname>Minakata</surname><given-names>Nobuhisa</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4540-4036</contrib-id><xref rid="deo270077-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270077-cr-0003" contrib-type="author"><name><surname>Yamashita</surname><given-names>Riu</given-names></name><xref rid="deo270077-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="deo270077-cr-0004" contrib-type="author"><name><surname>Sakashita</surname><given-names>Shingo</given-names></name><xref rid="deo270077-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="deo270077-cr-0005" contrib-type="author"><name><surname>Yoda</surname><given-names>Yusuke</given-names></name><xref rid="deo270077-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270077-cr-0006" contrib-type="author"><name><surname>Ohashi</surname><given-names>Akihiro</given-names></name><xref rid="deo270077-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="deo270077-cr-0007" contrib-type="author"><name><surname>Aoshima</surname><given-names>Masato</given-names></name><xref rid="deo270077-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="deo270077-cr-0008" contrib-type="author"><name><surname>Kobayashi</surname><given-names>Susumu</given-names></name><xref rid="deo270077-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><xref rid="deo270077-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="deo270077-cr-0009" contrib-type="author" corresp="yes"><name><surname>Yano</surname><given-names>Tomonori</given-names></name><xref rid="deo270077-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>toyano@east.ncc.go.jp</email></address></contrib></contrib-group><aff id="deo270077-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology and Endoscopy</named-content>
<institution>National Cancer Center Hospital East</institution>
<named-content content-type="country-part">Chiba</named-content>
<country country="JP">Japan</country>
</aff><aff id="deo270077-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology</named-content>
<institution>IMSUT Hospital, The Institute of Medical Science, The University of Tokyo</institution>
<named-content content-type="country-part">Tokyo</named-content>
<country country="JP">Japan</country>
</aff><aff id="deo270077-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Division of Translational Informatics, Exploratory Oncology Research &#x00026; Clinical Trial Center</named-content>
<institution>National Cancer Center</institution>
<named-content content-type="country-part">Chiba</named-content>
<country country="JP">Japan</country>
</aff><aff id="deo270077-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Pathology and Clinical Laboratories</named-content>
<institution>National Cancer Center Hospital East</institution>
<named-content content-type="country-part">Chiba</named-content>
<country country="JP">Japan</country>
</aff><aff id="deo270077-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Division of Translational Genomics, Exploratory Oncology Research &#x00026; Clinical Trial Center</named-content>
<institution>National Cancer Center</institution>
<named-content content-type="country-part">Chiba</named-content>
<country country="JP">Japan</country>
</aff><aff id="deo270077-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Department of Medicine, Beth Israel Deaconess Medical Center</named-content>
<institution>Harvard Medical School</institution>
<city>Boston</city>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Tomonori Yano, Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, 6&#x02010;5&#x02010;1, Kashiwanoha, Kashiwa, Chiba 277&#x02010;8577, Japan.<break/> Email: <email>toyano@east.ncc.go.jp</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="12">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e70077</elocation-id><history>
<date date-type="rev-recd"><day>20</day><month>1</month><year>2025</year></date>
<date date-type="received"><day>17</day><month>10</month><year>2024</year></date>
<date date-type="accepted"><day>01</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e70077.pdf"/><abstract><title>Abstract</title><p>Oxygen saturation imaging is a new technology that determines biological features from the perspective of oxygen concentration. Therefore, this exploratory study aimed to evaluate the biological implications of oxygen saturation imaging and further assess tumor heterogeneity in gastric cancer. Biopsy samples were selectively obtained from treatment&#x02010;na&#x000ef;ve patients with gastric cancer under real&#x02010;time oxygen saturation imaging. Tissue oxygen saturation level calculations, immunohistochemistry, and RNA sequencing were performed. The mean tissue oxygen saturation levels at the sampling sites were 32.2%, 70.8%, and 56.2% for hypoxic, hyperoxic, and non&#x02010;tumor areas, respectively, with significant differences between each pair. CD&#x02010;31 and glucose transporter 1 protein expression were significantly upregulated in hypoxic tumors. Comprehensive transcriptomic analysis revealed enriched biological processes related to the regulation of insulin&#x02010;like growth factor transport and uptake by insulin&#x02010;like growth factor&#x02010;binding proteins in hypoxic tumors and the type I interferon signaling pathway in hyperoxic tumors. Oxygen saturation imaging has the potential to clarify hypoxia&#x02010;induced heterogeneity in gastric cancer from both clinical and fundamental perspectives.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo270077-kwd-0001">endoscopy</kwd><kwd id="deo270077-kwd-0002">heterogeneity</kwd><kwd id="deo270077-kwd-0003">oxygen saturation</kwd><kwd id="deo270077-kwd-0004">stomach neoplasms</kwd><kwd id="deo270077-kwd-0005">tumor hypoxia</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Japan Society for the Promotion of Science
</institution><institution-id institution-id-type="doi">10.13039/501100001691</institution-id></institution-wrap></funding-source><award-id>JP20K16319 to Tatsunori Minamide</award-id><award-id>JP16K21746 to Susumu Kobayashi</award-id></award-group><award-group id="funding-0002"><funding-source>National Cancer Center Research and Development Fund</funding-source><award-id>2020&#x02010;A&#x02010;10 to Tomonori Yano</award-id></award-group></funding-group><counts><fig-count count="3"/><table-count count="2"/><page-count count="8"/><word-count count="3385"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo270077-sec-0010"><title>INTRODUCTION</title><p>Hypoxia is a common solid tumor characteristic caused by uncontrolled cell proliferation and incomplete angiogenesis.<xref rid="deo270077-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> By upregulating the master transcription factor hypoxia&#x02010;inducible factor&#x02010;1 (HIF&#x02010;1), the hypoxic microenvironment plays a pivotal role in tumor progression by promoting biological processes, including angiogenesis, glucose metabolism, invasion, and metastasis.<xref rid="deo270077-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo270077-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> Intratumoral hypoxia is associated with oncological therapeutic resistance of various solid tumors; however, the biological background of oxygen heterogeneity has not been elucidated, particularly in gastric cancer, which harbors high biological heterogeneity.<xref rid="deo270077-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>
</p><p>Oxygen saturation (OS) imaging, a novel endoscopic gastrointestinal technique, allows real&#x02010;time visualization of saturation of tissue oxygen (StO<sub>2</sub>) levels by displaying them as pseudocolor images on the mucosal surface. The OS imaging system is based on the spectral differences between oxyhemoglobin and deoxyhemoglobin. As previously described, we used two laser diodes with different wavelengths (445 and 473&#x000a0;nm).<xref rid="deo270077-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> While various endoscopic approaches have been developed for the accurate detection and qualitative diagnosis of gastrointestinal cancer, OS imaging is a new technology that determines biological features from an oxygen concentration perspective. Therefore, this exploratory study aimed to evaluate the biological implications of OS imaging and assess intratumoral heterogeneity in gastric cancer based on OS imaging with selective tissue biopsies.</p></sec><sec id="deo270077-sec-0020"><title>PROCEDURE OR TECHNIQUE</title><sec id="deo270077-sec-0030"><title>Study design and patients</title><p>This observational study was conducted between November 2019 and April 2020 at a tertiary referral center in Japan. The inclusion criterion was patients with treatment&#x02010;na&#x000ef;ve gastric cancer scheduled to undergo esophagogastroduodenoscopy (EGD) for endoscopic lesion diagnosis and tumor sampling. The exclusion criterion was patients who could not undergo EGD with accurate StO<sub>2</sub> measurement by OS imaging because of adherent substances, including blood and white coating.</p><p>Written informed consent for study participation was obtained from all patients before the endoscopic procedures. This study was approved by the Institutional Review Board of the National Cancer Center Hospital East (registration number 2019&#x02013;076) and conducted according to the 1964 Declaration of Helsinki and its later amendments.</p></sec><sec id="deo270077-sec-0040"><title>Clinicopathological data collection</title><p>The following clinicopathological data were collected from the patient's electronic medical records: age, sex, tumor location, macroscopic tumor type, tumor size, histopathological type, and clinical stage.</p></sec><sec id="deo270077-sec-0050"><title>Endoscopic procedure</title><p>All EGDs were performed for OS imaging using the LASEREO system and EG&#x02010;L590ZW (FUJIFILM Co., Tokyo, Japan). Only board&#x02010;certified endoscopists performed the EGDs. Endoscopic images of white light and the OS were captured simultaneously and projected onto two screens. Real&#x02010;time OS imaging was projected as a pseudocolor endoscopic image depending on the StO<sub>2</sub> levels, enabling the endoscopists to predict StO<sub>2</sub> levels from the color differences (Figure&#x000a0;<xref rid="deo270077-fig-0001" ref-type="fig">1a</xref>). Two biopsy samples were selectively obtained from each non&#x02010;tumor area and hypoxic and hyperoxic tumor area (one each for immunohistochemistry and RNA sequencing), as determined by OS imaging. Since there was no clear definition of hypoxic and hyperoxic tumors under OS imaging, the endoscopists determined relative hypoxic and hyperoxic areas within the same tumor at the time of observation. After thoroughly washing and removing mucus, bile, blood, and other adherent materials that could affect OS imaging,<xref rid="deo270077-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> a biopsy was taken from a non&#x02010;tumor area at least 1&#x000a0;cm away from the tumor. After EGD completion, the obtained endoscopic images were used to measure StO<sub>2</sub> levels at the sampling sites using dedicated software developed by FUJIFILM Co. StO<sub>2</sub> levels were calculated as the average value within a small square at the sampling site.</p><fig position="float" fig-type="FIGURE" id="deo270077-fig-0001"><label>FIGURE 1</label><caption><p>Oxygen saturation imaging and tissue oxygen saturation measurement. (a) Representative endoscopic images acquired using oxygen saturation imaging. In this case, tissue oxygen saturation (StO<sub>2</sub>) levels for hypoxic (white dashed box) and hyperoxic tumor areas (black box) were 31% and 60%, respectively. (b) StO<sub>2</sub> levels in hypoxic tumors, hyperoxic tumors, and non&#x02010;tumor areas, from which biopsy samples were obtained using real&#x02010;time oxygen saturation imaging. *<italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.05.</p></caption><graphic xlink:href="DEO2-5-e70077-g002" position="anchor" id="jats-graphic-1"/></fig></sec><sec id="deo270077-sec-0060"><title>Immunohistochemistry</title><p>Immunohistochemistry was performed on sections (5&#x000a0;&#x000b5;m thickness) dissected from formalin&#x02010;fixed paraffin&#x02010;embedded biopsy samples. After deparaffinization, rehydration, and antigen retrieval using microwave heating, the endogenous peroxidase activity was blocked using 0.3 % hydrogen peroxide/methanol for 30&#x000a0;min at room temperature. The sections were incubated with primary antibodies against CD&#x02010;31 (M0823; Dako, Glostrup, Denmark) at a dilution of 1:200 and glucose transporter 1 (GLUT&#x02010;1; sc&#x02010;377228; Santa Cruz Biotechnology, CA, USA) at the same dilution overnight at 4&#x000b0;C. Subsequently, the sections were incubated with horseradish peroxidase&#x02010;conjugated secondary antibodies for 30&#x000a0;min at room temperature. Finally, the sections were stained with diaminobenzidine solution for 15&#x000a0;min, followed by counterstaining with hematoxylin. Three rectangular fields (0.1&#x000a0;mm<sup>2</sup>) were randomly selected under a light microscope and processed using a computer&#x02010;aided automatic image analysis system (HALO; Indica Labs, NM, USA). For CD&#x02010;31, the stain&#x02010;positive area per field of view was calculated. For GLUT1, the H&#x02010;score was used for semi&#x02010;quantitative expression assessment. The H&#x02010;score was calculated by grading the staining intensity into four levels (none, weak, moderate, and strong staining), multiplying the cell percentage in each grade by 0&#x02013;3, and then summing the results.</p></sec><sec id="deo270077-sec-0070"><title>RNA sequencing analysis</title><p>Total RNA was extracted from the biopsy samples using the RNeasy Mini Kit (Qiagen, USA), according to the manufacturer's instructions. Complementary DNA library construction and sequencing were performed on the BGISEQ&#x02010;500 platform. High&#x02010;quality reads were aligned with the human reference genome (GRCh38) using spliced transcript alignment to a reference (STAR) software. The expression level of each gene was normalized to the transcripts per kilobase of the exon model per million mapped reads using RNA sequencing with expectation maximization. ComBat&#x02010;seq was used to eliminate batch effects. For transcriptomic analysis, differentially expressed genes were selected between hypoxic and hyperoxic tumors according to the combination of the absolute value of log2&#x02010;Ratio&#x000a0;&#x0003e;&#x000a0;1 and false discovery rate&#x000a0;&#x0003c;&#x000a0;0.01. Gene ontology analysis of differentially expressed genes was performed using Metascape (<ext-link xlink:href="http://metascape.org" ext-link-type="uri">http://metascape.org</ext-link>).</p></sec><sec id="deo270077-sec-0080"><title>Statistical analysis</title><p>Categorical data were expressed as frequencies (%). Continuous variables were expressed as medians with ranges and compared using Student's t&#x02010;test or one&#x02010;way analysis of variance with appropriate Bonferroni's post&#x02010;hoc tests. All statistical analyses were performed using EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), a graphical user interface for R (R Foundation for Statistical Computing, Vienna, Austria). Statistical significance was set at <italic toggle="yes">P</italic>&#x000a0;&#x0003c;&#x000a0;0.05.</p></sec></sec><sec id="deo270077-sec-0090"><title>RESULTS</title><p>We recruited six patients with treatment&#x02010;na&#x000ef;ve gastric cancer who underwent EGD for lesion diagnosis using OS imaging. Most cases were of advanced and pathologically differentiated cancer types (Table&#x000a0;<xref rid="deo270077-tbl-0001" ref-type="table">1</xref>). All lesions were reddish type 2 or 3 ulcerative lesions. To confirm whether pseudocolor endoscopic images by OS imaging correlated with StO<sub>2</sub> levels, we calculated StO<sub>2</sub> levels at the sampling sites, which endoscopists determined to be hypoxic or hyperoxic using real&#x02010;time OS imaging (Figure&#x000a0;<xref rid="deo270077-fig-0001" ref-type="fig">1a</xref>). We observed a clear correlation between StO<sub>2</sub> levels and sampling sites, with means of 32.2 %, 70.8 %, and 56.2 % for hypoxic, hyperoxic, and non&#x02010;tumor areas, respectively. This finding demonstrates significant differences between the pairs (Figure&#x000a0;<xref rid="deo270077-fig-0001" ref-type="fig">1b</xref>). Real&#x02010;time OS imaging was confirmed to be beneficial in estimating StO<sub>2</sub> levels, highlighting significant intratumoral oxygen heterogeneity.</p><table-wrap position="float" id="deo270077-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Baseline clinicopathological characteristics of six patients with gastric cancer.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">n</italic>&#x000a0;= 6</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, median, years (range)</td><td align="left" rowspan="1" colspan="1">73 (60&#x02013;84)</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">4 (66.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">2 (33.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Location, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Upper third</td><td align="left" rowspan="1" colspan="1">2 (33.3)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Middle third</td><td align="left" rowspan="1" colspan="1">3 (50.0)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Lower third</td><td align="left" rowspan="1" colspan="1">1 (16.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Macroscopic type, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type 2</td><td align="left" rowspan="1" colspan="1">4 (66.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type 3</td><td align="left" rowspan="1" colspan="1">2 (33.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Size, median, mm (range)</td><td align="left" rowspan="1" colspan="1">48 (28&#x02013;100)</td></tr><tr><td align="left" rowspan="1" colspan="1">Histopathological type, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Differentiated</td><td align="left" rowspan="1" colspan="1">5 (83.3)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Undifferentiated</td><td align="left" rowspan="1" colspan="1">1 (16.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Stage, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">1 (16.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">III</td><td align="left" rowspan="1" colspan="1">4 (66.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">1 (16.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Helicobacter pylori</italic> infection status, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Uninfected</td><td align="left" rowspan="1" colspan="1">1 (16.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Infected</td><td align="left" rowspan="1" colspan="1">4 (66.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">1 (16.7)</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>To determine the biological significance of OS imaging, we investigated the protein expressions of CD&#x02010;31 and GLUT&#x02010;1 using immunohistochemistry (Figure&#x000a0;<xref rid="deo270077-fig-0002" ref-type="fig">2a</xref>). CD&#x02010;31 is a microvascular endothelial cell marker. GLUT&#x02010;1 is responsible for glucose uptake, and the HIF&#x02010;1 cascade induces its transcription under hypoxic conditions.<xref rid="deo270077-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> Notably, the hypoxic tumors had significantly greater CD&#x02010;31 stain&#x02010;positive areas per field of view than the hyperoxic tumors and non&#x02010;tumor areas (16.8 % vs. 9.4 % vs. 4.1 %; Figure&#x000a0;<xref rid="deo270077-fig-0002" ref-type="fig">2b</xref>). Additionally, the H&#x02010;scores for GLUT&#x02010;1 were significantly higher in hypoxic tumors than in hyperoxic tumors and non&#x02010;tumor areas (19.9&#x000a0;vs. 3.7&#x000a0;vs. 0.0). These findings suggest a correlation between OS imaging and the upregulation of biological processes in hypoxic tumors.</p><fig position="float" fig-type="FIGURE" id="deo270077-fig-0002"><label>FIGURE 2</label><caption><p>Immunohistochemistry based on oxygen saturation heterogeneity. (a) Representative immunohistochemical staining images of biopsy samples from gastric cancers with CD&#x02010;31 and glucose transporter 1 (GLUT&#x02010;1). The top row shows the stained images, and the bottom row shows the resulting images from the computer&#x02010;assisted analysis. The scale bars correspond to 100&#x000a0;&#x000b5;m. (b) Quantitative and semi&#x02010;quantitative immunohistochemistry image evaluation of CD&#x02010;31 and GLUT&#x02010;1 in hypoxic tumors, hyperoxic tumors, and non&#x02010;tumor areas. The stain&#x02010;positive areas per field of view for CD&#x02010;31 (left) and the H&#x02010;score for GLUT&#x02010;1 (right) were assessed. *<italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.05.</p></caption><graphic xlink:href="DEO2-5-e70077-g001" position="anchor" id="jats-graphic-3"/></fig><p>RNA sequencing was performed on each biopsy sample to compare comprehensive gene expression profiles using OS imaging. Quality control data are presented in Table <xref rid="deo270077-supinfo-0001" ref-type="">S1</xref>. The principal component analysis demonstrated a significant transcriptomic difference between tumor and non&#x02010;tumor tissues, confirming exact tumor sampling (Figure&#x000a0;<xref rid="deo270077-fig-0003" ref-type="fig">3a</xref>). In addition, the hierarchical clustering analysis showed greater interpatient heterogeneity than intrapatient heterogeneity (Figure&#x000a0;<xref rid="deo270077-fig-0003" ref-type="fig">3b</xref>). Figure&#x000a0;<xref rid="deo270077-fig-0003" ref-type="fig">3c</xref> shows the expression of HIF1A, SCL2A1, and PECAM1, representative genes of the HIF&#x02010;1 cascade. However, the correlation between groups was less pronounced compared to immunohistochemical staining. Gene ontology analysis of the differentially expressed genes (Table <xref rid="deo270077-supinfo-0001" ref-type="">S2</xref>) revealed that distinct pathways were activated in response to StO<sub>2</sub> (Figure&#x000a0;<xref rid="deo270077-fig-0003" ref-type="fig">3d</xref> and Table&#x000a0;<xref rid="deo270077-tbl-0002" ref-type="table">2</xref>). In hypoxic tumors, the biological processes related to the regulation of insulin&#x02010;like growth factor (IGF) transport and uptake by IGF&#x02010;binding proteins were enriched. In hyperoxic tumors, biological processes related to the type I interferon signaling pathway were enriched. Collectively, our comprehensive transcriptomic gastric cancer analysis delineated the biological differences between hypoxic and hyperoxic tumors based on selective tissue sampling using OS imaging.</p><fig position="float" fig-type="FIGURE" id="deo270077-fig-0003"><label>FIGURE 3</label><caption><p>Comprehensive transcriptomic analysis depending on oxygen saturation heterogeneity. (a) Principal component analysis and (b) hierarchical clustering analysis of the comprehensive gene expression profiles for each area using oxygen saturation imaging. (c) Expression of HIF1A, SCL2A1, and PECAM1, representative genes of the HIF&#x02010;1 cascade. (d) Gene ontology analysis of differentially expressed genes in hypoxic (upper panel) and hyperoxic (lower panel) tumors. Only the biological processes of interest were annotated. The non&#x02010;tumor area of Case 4 was not analyzed because RNA of sufficient quality could not be obtained.</p></caption><graphic xlink:href="DEO2-5-e70077-g003" position="anchor" id="jats-graphic-5"/></fig><table-wrap position="float" id="deo270077-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Results of gene ontology analysis of the differentially expressed genes.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr><th align="left" colspan="3" style="border-bottom:solid 1px #000000" rowspan="1">Hypoxic tumor</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Term</th><th align="left" rowspan="1" colspan="1">Description</th><th align="left" rowspan="1" colspan="1">&#x02010;Log10 (<italic toggle="yes">p</italic>)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ko05322</td><td align="left" rowspan="1" colspan="1">Systemic lupus erythematosus</td><td align="left" rowspan="1" colspan="1">13.3467011172</td></tr><tr><td align="left" rowspan="1" colspan="1">R&#x02010;HSA&#x02010;381426</td><td align="left" rowspan="1" colspan="1">Regulation of insulin&#x02010;like growth factor (IGF) transport and uptake by insulin&#x02010;like growth factor binding proteins (IGFBPs)</td><td align="left" rowspan="1" colspan="1">9.3896787623</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007268</td><td align="left" rowspan="1" colspan="1">Chemical synaptic transmission</td><td align="left" rowspan="1" colspan="1">7.6538316517</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0098742</td><td align="left" rowspan="1" colspan="1">Cell&#x02010;cell adhesion via plasma&#x02010;membrane adhesion molecules</td><td align="left" rowspan="1" colspan="1">7.1964942062</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:2000609</td><td align="left" rowspan="1" colspan="1">Regulation of thyroid hormone generation</td><td align="left" rowspan="1" colspan="1">6.5073450224</td></tr><tr><td align="left" rowspan="1" colspan="1">R&#x02010;HSA&#x02010;977225</td><td align="left" rowspan="1" colspan="1">Amyloid fiber formation</td><td align="left" rowspan="1" colspan="1">6.0569753008</td></tr><tr><td align="left" rowspan="1" colspan="1">R&#x02010;HSA&#x02010;174577</td><td align="left" rowspan="1" colspan="1">Activation of C3 and C5</td><td align="left" rowspan="1" colspan="1">5.8466870726</td></tr><tr><td align="left" rowspan="1" colspan="1">hsanan01</td><td align="left" rowspan="1" colspan="1">Drug metabolism</td><td align="left" rowspan="1" colspan="1">5.7734696832</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa05032</td><td align="left" rowspan="1" colspan="1">Morphine addiction</td><td align="left" rowspan="1" colspan="1">4.7855927151</td></tr><tr><td align="left" rowspan="1" colspan="1">M5885</td><td align="left" rowspan="1" colspan="1">NABA MATRISOME ASSOCIATED</td><td align="left" rowspan="1" colspan="1">4.7485822404</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002576</td><td align="left" rowspan="1" colspan="1">Platelet degranulation</td><td align="left" rowspan="1" colspan="1">4.5394056396</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0042060</td><td align="left" rowspan="1" colspan="1">Wound healing</td><td align="left" rowspan="1" colspan="1">4.3681574021</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0019730</td><td align="left" rowspan="1" colspan="1">Antimicrobial humoral response</td><td align="left" rowspan="1" colspan="1">4.30879</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0043269</td><td align="left" rowspan="1" colspan="1">Regulation of ion transport</td><td align="left" rowspan="1" colspan="1">4.21892</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0015850</td><td align="left" rowspan="1" colspan="1">Organic hydroxy compound transport</td><td align="left" rowspan="1" colspan="1">3.937614757</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0015893</td><td align="left" rowspan="1" colspan="1">Drug transport</td><td align="left" rowspan="1" colspan="1">3.888465331</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0071248</td><td align="left" rowspan="1" colspan="1">Cellular response to metal ion</td><td align="left" rowspan="1" colspan="1">3.88206399</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007389</td><td align="left" rowspan="1" colspan="1">Pattern specification process</td><td align="left" rowspan="1" colspan="1">3.809581543</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016338</td><td align="left" rowspan="1" colspan="1">Calcium&#x02010;independent cell&#x02010;cell adhesion via plasma membrane cell&#x02010;adhesion molecules</td><td align="left" rowspan="1" colspan="1">3.807009539</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0045995</td><td align="left" rowspan="1" colspan="1">Regulation of embryonic development</td><td align="left" rowspan="1" colspan="1">3.626085612</td></tr></tbody></table><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr><th align="left" colspan="3" style="border-bottom:solid 1px #000000" rowspan="1">Hyperoxic tumor</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Term</th><th align="left" rowspan="1" colspan="1">Description</th><th align="left" rowspan="1" colspan="1">&#x02010;log10 (<italic toggle="yes">p</italic>)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GO:0060337</td><td align="left" rowspan="1" colspan="1">Type I interferon signaling pathway</td><td align="left" rowspan="1" colspan="1">8.38375127</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006638</td><td align="left" rowspan="1" colspan="1">neutral lipid metabolic process</td><td align="left" rowspan="1" colspan="1">7.879192364</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050892</td><td align="left" rowspan="1" colspan="1">Intestinal absorption</td><td align="left" rowspan="1" colspan="1">7.599153023</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006066</td><td align="left" rowspan="1" colspan="1">Alcohol metabolic process</td><td align="left" rowspan="1" colspan="1">5.684823922</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016266</td><td align="left" rowspan="1" colspan="1">O&#x02010;glycan processing</td><td align="left" rowspan="1" colspan="1">5.069585304</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048608</td><td align="left" rowspan="1" colspan="1">Reproductive structure development</td><td align="left" rowspan="1" colspan="1">4.901162304</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048732</td><td align="left" rowspan="1" colspan="1">Gland development</td><td align="left" rowspan="1" colspan="1">4.901162304</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009410</td><td align="left" rowspan="1" colspan="1">Response to xenobiotic stimulus</td><td align="left" rowspan="1" colspan="1">4.758520467</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0008610</td><td align="left" rowspan="1" colspan="1">Lipid biosynthetic process</td><td align="left" rowspan="1" colspan="1">4.657150014</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0060290</td><td align="left" rowspan="1" colspan="1">Transdifferentiation</td><td align="left" rowspan="1" colspan="1">4.584290413</td></tr><tr><td align="left" rowspan="1" colspan="1">M106</td><td align="left" rowspan="1" colspan="1">PID HNF3B PATHWAY</td><td align="left" rowspan="1" colspan="1">4.567164798</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0031018</td><td align="left" rowspan="1" colspan="1">Endocrine pancreas development</td><td align="left" rowspan="1" colspan="1">4.567164798</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0021987</td><td align="left" rowspan="1" colspan="1">cerebral cortex development</td><td align="left" rowspan="1" colspan="1">4.30303585</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002065</td><td align="left" rowspan="1" colspan="1">Columnar/cuboidal epithelial cell differentiation</td><td align="left" rowspan="1" colspan="1">4.30303585</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002685</td><td align="left" rowspan="1" colspan="1">Regulation of leukocyte migration</td><td align="left" rowspan="1" colspan="1">4.292608622</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048469</td><td align="left" rowspan="1" colspan="1">Cell maturation</td><td align="left" rowspan="1" colspan="1">4.043451304</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:1903532</td><td align="left" rowspan="1" colspan="1">Positive regulation of secretion by cell</td><td align="left" rowspan="1" colspan="1">4.042071918</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0010960</td><td align="left" rowspan="1" colspan="1">Magnesium ion homeostasis</td><td align="left" rowspan="1" colspan="1">4.000161862</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0035404</td><td align="left" rowspan="1" colspan="1">Histone&#x02010;serine phosphorylation</td><td align="left" rowspan="1" colspan="1">4.000161862</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0120162</td><td align="left" rowspan="1" colspan="1">Positive regulation of cold&#x02010;induced thermogenesis</td><td align="left" rowspan="1" colspan="1">3.921200439</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo270077-sec-0100"><title>DISCUSSION</title><p>To our knowledge, this is the first study to evaluate OS imaging focusing on oncological implications, particularly intratumoral heterogeneity. We have previously reported the usefulness of this technology in assessing decreased blood flow, that is, acute hypoxia.<xref rid="deo270077-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="deo270077-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Our data demonstrated that real&#x02010;time OS imaging also serves as a powerful endoscopic tool for precise intratumoral hypoxia assessment, which has long been difficult to determine within the human body.</p><p>Compared to existing imaging techniques, including needle electrode systems and positron emission tomography,<xref rid="deo270077-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> OS imaging is a minimally invasive and high&#x02010;resolution technique for assessing intratumoral hypoxia. Moreover, this technique does not require additional devices or dyes; it requires the endoscopist to push a button on the endoscope, allowing for rapid and comprehensive assessment of heterogeneous StO<sub>2</sub> levels. Besides OS imaging, various other endoscopic developments for measuring StO<sub>2</sub> levels have been attempted.<xref rid="deo270077-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="deo270077-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="deo270077-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="deo270077-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> Innovative technologies were applied, such as thermal imaging, photoacoustic imaging, and hyperspectral imaging. Although some have been validated in vivo, there are few reports of their actual usefulness in the human body compared to OS imaging.</p><p>Under hypoxic conditions, tumor cells adjust their metabolic programs and promote angiogenesis and metastasis, as well as DNA repair and immune escape by activating HIF&#x02010;1 expression.<xref rid="deo270077-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo270077-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="deo270077-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> HIF&#x02010;1 induces vascular endothelial growth factor and basic fibroblast growth factor, which increases vascular endothelial cells and enhances vascular permeability.<xref rid="deo270077-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="deo270077-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> As hypoxia was reported to be associated with GLUT&#x02010;1 expression and <sup>18</sup>F&#x02010;fluorodeoxyglucose uptake in disseminated peritoneal tumors,<xref rid="deo270077-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> HIF&#x02010;1 transcription also results in upregulation of glucose transporters. However, hyperoxia has been reported to activate the antitumor immune cells by weakening the hypoxia&#x02013;A2&#x02010;adenosinergic immunosuppression.<xref rid="deo270077-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>
</p><p>Herein, we elucidated the biological implications of OS imaging using protein and gene expression analyses based on selective tissue biopsies from hypoxic and hyperoxic tumors. Intriguingly, protein expression analysis revealed that hypoxic areas, as determined by OS imaging, correlate with angiogenesis and glucose metabolism enhancements, which are associated with tumor hypoxia.<xref rid="deo270077-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo270077-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="deo270077-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Therefore, OS imaging in clinical settings reflects the biological dynamics of gastric cancer. Furthermore, the comprehensive transcriptomic analysis demonstrated that tumor heterogeneity depends on StO<sub>2</sub> levels and the characteristic biological program enrichment related to intratumoral hypoxia and hyperoxia. The IGF pathway reportedly contributes to treatment resistance in lung cancer via hypoxia,<xref rid="deo270077-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> and recent studies have revealed that the type I interferon pathway is downregulated in several hypoxia&#x02010;induced cancers. Our findings and these data may provide clues to elucidate hypoxia&#x02010;induced resistance mechanisms using OS imaging.<xref rid="deo270077-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>
</p><p>Although the limitations of this exploratory study are that it included only a small number of cases and lacked a clear definition of hypoxic and hyperoxic areas, our observations will allow OS imaging to be a revolutionary tool in future studies focusing on tissue oxygen heterogeneity in gastrointestinal cancers from both clinical and basic medical perspectives. We believe that OS imaging has the potential to clarify the molecular mechanisms of the hypoxic tumor microenvironment, predict therapeutic effects, and resolve treatment resistance due to oxygen heterogeneity.</p></sec><sec sec-type="COI-statement" id="deo270077-sec-0110"><title>CONFLICT OF INTEREST STATEMENT</title><p>Tomonori Yano is Deputy Editor&#x02010;in&#x02010;Chief of Digestive Endoscopy and received a research grant from FUJIFILM for this study, which provided the oxygen saturation imaging endoscopy system used in this research. The remaining authors have no conflict of interest.</p></sec><sec id="deo270077-sec-0120"><title>ETHICS STATEMENT</title><p>Approval of the research protocol by an Institutional Reviewer Board: The Institutional Review Board of the National Cancer Center Hospital East approved the research protocol (registration number 2019&#x02013;076).</p></sec><sec id="deo270077-sec-0130"><title>PATIENT CONSENT STATEMENT</title><p>Written informed consent for study participation was obtained from all patients before the endoscopic procedures.</p></sec><sec id="deo270077-sec-0140"><title>CLINICAL TRIAL REGISTRATION</title><p>N/A.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="deo270077-supinfo-0001" position="float" content-type="local-data"/><supplementary-material id="deo270077-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>TABLE S1</bold> Quality control data of RNA sequencing.</p></caption><media xlink:href="DEO2-5-e70077-s002.docx"/></supplementary-material><supplementary-material id="deo270077-supitem-0002" position="float" content-type="local-data"><caption><p>
<bold>TABLE S2</bold> Top 20 differentially expressed genes in hypoxic tumor compared to hyperoxic tumor.</p></caption><media xlink:href="DEO2-5-e70077-s001.docx"/></supplementary-material></sec></body><back><ref-list id="deo270077-bibl-0001"><title>REFERENCES</title><ref id="deo270077-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo270077-cite-0001">
<string-name>
<surname>Horsman</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Mortensen</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Petersen</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Busk</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Overgaard</surname>
<given-names>J</given-names>
</string-name>. <article-title>Imaging hypoxia to improve radiotherapy outcome</article-title>. <source>Nat Rev Clin Oncol</source>
<year>2012</year>; <volume>9</volume>: <fpage>674</fpage>&#x02013;<lpage>687</lpage>.<pub-id pub-id-type="pmid">23149893</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo270077-cite-0002">
<string-name>
<surname>Semenza</surname>
<given-names>GL</given-names>
</string-name>. <article-title>Hypoxia&#x02010;inducible factors in physiology and medicine</article-title>. <source>Cell</source>
<year>2012</year>; <volume>148</volume>: <fpage>399</fpage>&#x02013;<lpage>408</lpage>.<pub-id pub-id-type="pmid">22304911</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo270077-cite-0003">
<string-name>
<surname>Semenza</surname>
<given-names>GL</given-names>
</string-name>. <article-title>Targeting HIF&#x02010;1 for cancer therapy</article-title>. <source>Nat Rev Cancer</source>
<year>2003</year>; <volume>3</volume>: <fpage>721</fpage>&#x02013;<lpage>732</lpage>.<pub-id pub-id-type="pmid">13130303</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo270077-cite-0004">
<string-name>
<surname>Smyth</surname>
<given-names>EC</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Grabsch</surname>
<given-names>HI</given-names>
</string-name>, <string-name>
<surname>van Grieken</surname>
<given-names>NC</given-names>
</string-name>, <string-name>
<surname>Lordick</surname>
<given-names>F</given-names>
</string-name>. <article-title>Gastric cancer</article-title>. <source>Lancet</source>
<year>2020</year>; <volume>396</volume>: <fpage>635</fpage>&#x02013;<lpage>648</lpage>.<pub-id pub-id-type="pmid">32861308</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo270077-cite-0005">
<string-name>
<surname>Kaneko</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamaguchi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Hypoxia imaging endoscopy equipped with laser light source from preclinical live animal study to first&#x02010;in&#x02010;human subject research</article-title>. <source>PLoS One</source>
<year>2014</year>; <volume>9</volume>: <elocation-id>e99055</elocation-id>.<pub-id pub-id-type="pmid">24915532</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo270077-cite-0006">
<string-name>
<surname>Nishihara</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hori</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>A study of evaluating specific tissue oxygen saturation values of gastrointestinal tumors by removing adherent substances in oxygen saturation imaging</article-title>. <source>PLoS One</source>
<year>2021</year>; <volume>16</volume>: <elocation-id>e0243165</elocation-id>.<pub-id pub-id-type="pmid">33411775</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo270077-cite-0007">
<string-name>
<surname>Suyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yoda</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Oxygen saturation imaging as a useful tool for visualizing the mode of action of photodynamic therapy for esophageal cancer</article-title>. <source>VideoGIE</source>
<year>2020</year>; <volume>5</volume>: <fpage>496</fpage>&#x02013;<lpage>499</lpage>.<pub-id pub-id-type="pmid">33103009</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo270077-cite-0008">
<string-name>
<surname>Huang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>. <article-title>Imaging of tumor hypoxia with radionuclide&#x02010;labeled tracers for PET</article-title>. <source>Front Oncol</source>
<year>2021</year>; <volume>11</volume>: <elocation-id>731503</elocation-id>.<pub-id pub-id-type="pmid">34557414</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo270077-cite-0009">
<string-name>
<surname>Tepper</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Neeman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Milstein</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>David</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Gannot</surname>
<given-names>I</given-names>
</string-name>. <article-title>Thermal imaging method for estimating oxygen saturation</article-title>. <source>J Biomed Opt</source>
<year>2009</year>; <volume>14</volume>: <elocation-id>054048</elocation-id>.<pub-id pub-id-type="pmid">19895149</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo270077-cite-0010">
<string-name>
<surname>Yang</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Favazza</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>R</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Simultaneous functional photoacoustic and ultrasonic endoscopy of internal organs in vivo</article-title>. <source>Nat Med</source>
<year>2012</year>; <volume>18</volume>: <fpage>1297</fpage>&#x02013;<lpage>1302</lpage>.<pub-id pub-id-type="pmid">22797808</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo270077-cite-0011">
<string-name>
<surname>Li</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Clancy</surname>
<given-names>NT</given-names>
</string-name>, <string-name>
<surname>Elson</surname>
<given-names>DS</given-names>
</string-name>. <article-title>Estimation of tissue oxygen saturation from RGB images and sparse hyperspectral signals based on conditional generative adversarial network</article-title>. <source>Int J Comput Assist Radiol Surg</source>
<year>2019</year>; <volume>14</volume>: <fpage>987</fpage>&#x02013;<lpage>995</lpage>.<pub-id pub-id-type="pmid">30900114</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="deo270077-cite-0012">
<string-name>
<surname>Liu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Xing</surname>
<given-names>D</given-names>
</string-name>. <article-title>Photoacoustic and hyperspectral dual&#x02010;modality endoscope</article-title>. <source>Opt Lett</source>
<year>2018</year>; <volume>43</volume>: <fpage>138</fpage>&#x02013;<lpage>141</lpage>.<pub-id pub-id-type="pmid">29328216</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo270077-cite-0013">
<string-name>
<surname>Jing</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Shao</surname>
<given-names>C</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Role of hypoxia in cancer therapy by regulating the tumor microenvironment</article-title>. <source>Mol Cancer</source>
<year>2019</year>; <volume>18</volume>: <fpage>157</fpage>.<pub-id pub-id-type="pmid">31711497</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo270077-cite-0014">
<string-name>
<surname>Choueiri</surname>
<given-names>TK</given-names>
</string-name>. <article-title>Targeting the HIF2&#x02010;VEGF axis in renal cell carcinoma</article-title>. <source>Nat Med</source>
<year>2020</year>; <volume>26</volume>: <fpage>1519</fpage>&#x02013;<lpage>1530</lpage>.<pub-id pub-id-type="pmid">33020645</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo270077-cite-0015">
<string-name>
<surname>Calvani</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rapisarda</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Uranchimeg</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Shoemaker</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Melillo</surname>
<given-names>G</given-names>
</string-name>. <article-title>Hypoxic induction of an HIF&#x02010;1alpha&#x02010;dependent bFGF autocrine loop drives angiogenesis in human endothelial cells</article-title>. <source>Blood</source>
<year>2006</year>; <volume>107</volume>: <fpage>2705</fpage>&#x02013;<lpage>2712</lpage>.<pub-id pub-id-type="pmid">16304044</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo270077-cite-0016">
<string-name>
<surname>Li</surname>
<given-names>XF</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Humm</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Ling</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>O'Donoghue</surname>
<given-names>JA</given-names>
</string-name>. <article-title>High 18F&#x02010;FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia</article-title>. <source>J Nucl Med</source>
<year>2010</year>; <volume>51</volume>: <fpage>632</fpage>&#x02013;<lpage>638</lpage>.<pub-id pub-id-type="pmid">20351353</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo270077-cite-0017">
<string-name>
<surname>Hatfield</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Kjaergaard</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lukashev</surname>
<given-names>D</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Immunological mechanisms of the antitumor effects of supplemental oxygenation</article-title>. <source>Sci Transl Med</source>
<year>2015</year>; <volume>7</volume>: <elocation-id>277ra30</elocation-id>.</mixed-citation></ref><ref id="deo270077-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo270077-cite-0018">
<string-name>
<surname>Minakata</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Sakashita</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wakabayashi</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Immunohistochemistry and oxygen saturation endoscopic imaging reveal hypoxia in submucosal invasive esophageal squamous cell carcinoma</article-title>. <source>Cancer Med</source>
<year>2023</year>; <volume>12</volume>: <fpage>15809</fpage>&#x02013;<lpage>15819</lpage>.<pub-id pub-id-type="pmid">37329213</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo270077-cite-0019">
<string-name>
<surname>Murakami</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Nurwidya</surname>
<given-names>F</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Hypoxia increases gefitinib&#x02010;resistant lung cancer stem cells through the activation of insulin&#x02010;like growth factor 1 receptor</article-title>. <source>PLoS One</source>
<year>2014</year>; <volume>9</volume>: <elocation-id>e86459</elocation-id>.<pub-id pub-id-type="pmid">24489728</pub-id>
</mixed-citation></ref><ref id="deo270077-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="deo270077-cite-0020">
<string-name>
<surname>Miar</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Arnaiz</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bridges</surname>
<given-names>E</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Hypoxia induces transcriptional and translational downregulation of the Type I IFN pathway in multiple cancer cell types</article-title>. <source>Cancer Res</source>
<year>2020</year>; <volume>80</volume>: <fpage>5245</fpage>&#x02013;<lpage>5256</lpage>.<pub-id pub-id-type="pmid">33115807</pub-id>
</mixed-citation></ref></ref-list></back></article>